Back to trial details

Intake questionnaire

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Applying to Aqua Research Institute · Houston, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with End Stage Kidney Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Houston for study visits?